Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
A review of more than 600,000 Finnish births from 2006 to 2016 found that mothers with type 1 diabetes had more than four times as many children born with heart defects.
Read Full NewsAn AES study revealed the real-world persistence of fenfluramine in treating Lennox-Gastaut syndrome, highlighting patient demographics and treatment trends.
Final safety data from an open-label study presented at AES 2025 supported long-term fenfluramine use in pediatric and adult patients with Dravet syndrome or Lennox-Gastaut syndrome.
Low-Intensity Ultrasound Brain Stimulation Safely Reduces Depression Symptoms
Exercise May Be as Effective as Therapy for Alleviating Depression Symptoms
Parental Illness Perceptions Drive Poor QoL in Children with Food Allergies
Young Adults With Glomerular Disease May Require Distinct Care
Q4 2025 Recap: Nephrology News and Updates
1.
According to research, hospitals can save money and help cancer patients by implementing a basic intervention.
2.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
3.
Lung cancer screening adherence rates decline annually after baseline screening
4.
Sports for girls are frequently abandoned due to uniform issues.
5.
Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy
1.
Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research
2.
Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment
3.
The Benefits and Side Effects of Bortezomib in the Fight Against Cancer
4.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
5.
Everything You Need to Know About the Latest Hyponatremia Algorithm
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
2.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
3.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
4.
Updates on Standard V/S High Risk Myeloma Treatment
5.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge